Advaxis Inc. [NASDAQ: ADXS] closed the trading session at $0.51 on 10/19/21. The day’s price range saw the stock hit a low of $0.4802, while the highest price level was $0.5281. The company report on September 10, 2021 that Advaxis Reports 3rd Quarter Ended July 31, 2021 Financial Results and Provides a Business Update.
Entered definitive merger agreement with Biosight Ltd. to advance pipeline of clinical-stage oncology programs for solid tumors and hematological malignancies.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Initiated Phase 1 clinical trial of ADXS-504 for the treatment of early prostate cancer.
The stocks have a year to date performance of 45.71 percent and weekly performance of -0.41 percent. The stock has been moved at 7.60 percent over the last six months. The stock has performed 5.79 percent around the most recent 30 days and changed 14.26 percent over the most recent 3-months.
If compared to the average trading volume of 5.86M shares, ADXS reached to a volume of 7141722 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Advaxis Inc. [ADXS]:
Barclays have made an estimate for Advaxis Inc. shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on August 03, 2016. While these analysts kept the previous recommendation, Barclays raised their target price to Overweight. The new note on the price target was released on September 22, 2015, representing the official price target for Advaxis Inc. stock. Previously, the target price had yet another raise to $30, while Guggenheim analysts kept a Buy rating on ADXS stock. On June 16, 2015, analysts increased their price target for ADXS shares from 25 to 30.
The Average True Range (ATR) for Advaxis Inc. is set at 0.05, with the Price to Sales ratio for ADXS stock in the period of the last 12 months amounting to 23.82. The Price to Book ratio for the last quarter was 1.69, with the Price to Cash per share for the same quarter was set at 0.30.
ADXS stock trade performance evaluation
Advaxis Inc. [ADXS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.41. With this latest performance, ADXS shares gained by 5.79% in over the last four-week period, additionally plugging by 7.60% over the last 6 months – not to mention a rise of 10.46% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ADXS stock in for the last two-week period is set at 52.98, with the RSI for the last a single of trading hit 54.29, and the three-weeks RSI is set at 52.55 for Advaxis Inc. [ADXS]. The present Moving Average for the last 50 days of trading for this stock 0.4783, while it was recorded at 0.4953 for the last single week of trading, and 0.5868 for the last 200 days.
Advaxis Inc. [ADXS]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Advaxis Inc. [ADXS] shares currently have an operating margin of -9337.55. Advaxis Inc.’s Net Margin is presently recorded at -10462.06.
Return on Total Capital for ADXS is now -62.39, given the latest momentum, and Return on Invested Capital for the company is -70.80. Return on Equity for this stock declined to -75.94, with Return on Assets sitting at -63.18. When it comes to the capital structure of this company, Advaxis Inc. [ADXS] has a Total Debt to Total Equity ratio set at 19.94. Additionally, ADXS Total Debt to Total Capital is recorded at 16.62, with Total Debt to Total Assets ending up at 15.62. Long-Term Debt to Equity for the company is recorded at 16.75, with the Long-Term Debt to Total Capital now at 13.97.
Reflecting on the efficiency of the workforce at the company, Advaxis Inc. [ADXS] managed to generate an average of -$1,470,500 per employee.Advaxis Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 7.00 and a Current Ratio set at 7.00.
Advaxis Inc. [ADXS]: Insider Ownership positions
There are presently around $5 million, or 11.40% of ADXS stock, in the hands of institutional investors. The top three institutional holders of ADXS stocks are: VANGUARD GROUP INC with ownership of 5,750,482, which is approximately 47.435% of the company’s market cap and around 0.05% of the total institutional ownership; BLACKROCK INC., holding 1,251,191 shares of the stock with an approximate value of $0.64 million in ADXS stocks shares; and GEODE CAPITAL MANAGEMENT, LLC, currently with $0.52 million in ADXS stock with ownership of nearly 40.789% of the company’s market capitalization.
Positions in Advaxis Inc. stocks held by institutional investors increased at the end of September and at the time of the September reporting period, where 19 institutional holders increased their position in Advaxis Inc. [NASDAQ:ADXS] by around 3,227,201 shares. Additionally, 21 investors decreased positions by around 3,302,760 shares, while 9 investors held positions by with 3,429,930 shares. The mentioned changes placed institutional holdings at 9,959,891 shares, according to the latest SEC report filing. ADXS stock had 10 new institutional investments in for a total of 906,772 shares, while 10 institutional investors sold positions of 257,773 shares during the same period.